However, pairing GLP-1 drugs with DPP-4 inhibitors is generally avoided since both act on the same pathway, resulting in overlapping effects without meaningful added benefits
If you are exploring related products, you may also find value in learning about Zepbound KwikPen, another option in the incretin-based treatment category
However, both compounds individually cause: Nausea (60-80% of users at higher doses) Vomiting (20-35%) Diarrhea (25-40%) Injection site reactions (15-25%) Potential pancreatitis (rare but serious) Combining these compounds could theoretically amplify these effects, though the actual incidence and severity remain unstudied
Whilst anger issues are not a recognised side effect, your healthcare team can help determine whether your symptoms might be related to the medication, underlying health conditions, or other factors
Semaglutide was on the FDA shortage list for several years, allowing widespread compounding